908 Devices Inc's Suppliers recorded an increase in sales by 23.87 % year on year in Q2 2026, sequentially sales grew by 10.46 %, 908 Devices Inc recorded an increase in cost of sales by 28.85 % year on year, sequentially cost of sales grew by 28.85 % in Q2.
908 Devices Inc's Suppliers recorded an increase in sales by 23.87 % year on year in Q2 2026, sequentially sales grew by 10.46 %, 908 Devices Inc recorded increase in cost of sales by 28.85 % year on year, sequentially cost of sales grew by 28.85 % in Q2.
The company manufactures mass spectrometry and optical devices primarily at its facility in Danbury, Connecticut, supported by precision machining facilities in Stamford, Connecticut, and Georgetown, Massachusetts, all certified to ISO 9001:2015. Custom components such as printed circuit boards, cables, and certain metal and plastic mechanical parts are produced by third-party suppliers. Assembly of technology-sensitive components, including proprietary vacuum pumps, ion trap/ionization modules, and FTIR interferometer modules, is conducted in-house. The Danbury facility has an annual production capacity of approximately 1,000 mass spectrometry devices and 1,000 optical devices, with the ability to scale up to 5,000 combined devices with additional staffing. The company maintains relationships with various machine shops and electronics suppliers, including single-source suppliers for critical subassemblies such as the Raman spectrometer module. Consumables for the MX908 device are commercial off-the-shelf items from established suppliers, with sampling swabs currently single-sourced; alternative suppliers are believed to be available but require validation. The supply chain is continuously evaluated and diversified to meet customer demand and mitigate risks.
908 Devices Inc's Comment on Supply Chain
The company manufactures mass spectrometry and optical devices primarily at its facility in Danbury, Connecticut, supported by precision machining facilities in Stamford, Connecticut, and Georgetown, Massachusetts, all certified to ISO 9001:2015. Custom components such as printed circuit boards, cables, and certain metal and plastic mechanical parts are produced by third-party suppliers. Assembly of technology-sensitive components, including proprietary vacuum pumps, ion trap/ionization modules, and FTIR interferometer modules, is conducted in-house. The Danbury facility has an annual production capacity of approximately 1,000 mass spectrometry devices and 1,000 optical devices, with the ability to scale up to 5,000 combined devices with additional staffing. The company maintains relationships with various machine shops and electronics suppliers, including single-source suppliers for critical subassemblies such as the Raman spectrometer module. Consumables for the MX908 device are commercial off-the-shelf items from established suppliers, with sampling swabs currently single-sourced; alternative suppliers are believed to be available but require validation. The supply chain is continuously evaluated and diversified to meet customer demand and mitigate risks.
MASS's Suppliers Net Income grew by
MASS's Suppliers Net margin grew in Q2 to
1.23 %
MASS's Suppliers Net Income grew by
MASS's Suppliers Net margin grew in Q2 to 1.23 %
908 Devices Inc's Suppliers Sales Growth
in Q2 2026 by Industry
Sources:
908 Devices inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on 908 Devices inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
11.31 %